Pharmacologic treatment of fibromyalgia

被引：18

作者：

Baker K. ^{[1
]}

Barkhuizen A. ^{[1
]}

机构：

[1] Arthritis and Rheumatic Diseases, Oregon Health and Science University, Portland, OR 97239

来源：

Current Pain and Headache Reports | 2005年 / 9卷 / 5期

关键词：

Obstructive Sleep Apnea; Fluoxetine; Fibromyalgia; Tramadol; Duloxetine;

D O I：

10.1007/s11916-005-0003-x

中图分类号：

学科分类号：

摘要：

Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating a successful pharmacologic treatment program for patients with fibromyalgia. Copyright © 2005 by Current Science Inc.

引用

页码：301 / 306

页数：5

共 46 条

[1]

Bennett R., The rational management of fibromyalgia patients, Rheum. Dis. Clin. North Am., 28, pp. 181-199, (2002)

[2]

Wolfe F., Smythe H.A., Yunus M.B., Et al., The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee, Arthritis Rheum., 33, pp. 160-172, (1990)

[3]

Goldenberg D.L., Office management of fibromyalgia, Rheum. Dis. Clin. North Am., 28, pp. 437-446, (2002)

[4]

Burckhardt C.S., Mannerkorpi K., Hedenberg L., Bjelle A.A., Randomized, controlled clinical trial of education and physical training for women with fibromyalgia, J. Rheumatol., 21, pp. 714-720, (1994)

[5]

Burckhardt C.S., Bjelle A.A., Education programs for fibromyalgia patients: Description and evaluation, Baillieres Clin. Rheumatol., 8, pp. 935-955, (1994)

[6]

Bennett R., Emerging concepts in the neurobiology of chronic pain: Evidence of abnormal sensory processing in fibromyalgia, Mayo Clin. Proc., 74, pp. 385-398, (1999)

[7]

Barkhuizen A., Rational and targeted pharmacologic treatment of fibromyalgia, Rheum. Dis. Clin. North Am., 28, pp. 261-290, (2002)

[8]

Arnold L., Systemic therapies for chronic pain, Fibromyalgia and Other Central Pain Syndromes, pp. 365-388, (2005)

[9]

Goldbenberg D., Smith N., Fibromyalgia, rheumatologists, and the medical literature: A shaky alliance, J. Rheumatol., 30, pp. 151-153, (2003)

[10]

Goldenberg D., Burckhardt C., Crofford L., Management of fibromyalgia syndrome, JAMA, 292, pp. 2388-2395, (2004)

← 1 2 3 4 5 →